PubRank

T Höhler

Author PubWeight™ 17.29‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 [German S3-guideline "Diagnosis and treatment of esophagogastric cancer"]. Z Gastroenterol 2011 1.74
2 Differential regulation of interleukin-10 production by genetic and environmental factors--a twin study. Genes Immun 2002 1.39
3 Randomised phase II evaluation of irinotecan plus high-dose 5-fluorouracil and leucovorin (ILF) vs 5-fluorouracil, leucovorin, and etoposide (ELF) in untreated metastatic gastric cancer. Br J Cancer 2005 1.12
4 Genetic and environmental contributions to plasma C-reactive protein and interleukin-6 levels--a study in twins. Genes Immun 2006 1.10
5 Cetuximab in combination with weekly 5-fluorouracil/folinic acid and oxaliplatin (FUFOX) in untreated patients with advanced colorectal cancer: a phase Ib/II study of the AIO GI Group. Ann Oncol 2008 1.02
6 Viral and host factors in the prediction of response to interferon-alpha therapy in chronic hepatitis C after long-term follow-up. J Viral Hepat 1998 0.88
7 [Plexiform angiomyxoid myofibroblastic tumour of the stomach]. Pathologe 2012 0.87
8 Sequence analysis of the DRB1 promoter reveals limited polymorphism with no influence on gene expression. Genes Immun 2001 0.85
9 [Enteropathic spondylarthritis in chronic inflammatory bowel diseases: prevalence, manifestation pattern and HLA association]. Med Klin (Munich) 1996 0.84
10 Pathogenesis of human leukocyte antigen B27-positive arthritis. Information from clinical materials. Rheum Dis Clin North Am 1998 0.84
11 [TACE: therapy of the HCC before liver transplantation--experiences]. Rofo 2005 0.82
12 CD4+ and CD8+ clonal T cell expansions indicate a role of antigens in ankylosing spondylitis; a study in HLA-B27+ monozygotic twins. Clin Exp Immunol 2001 0.81
13 Veno-occlusive disease (VOD) in Crohn's disease (CD) treated with azathioprine. Dig Dis Sci 2003 0.80
14 IL10.G microsatellites mark promoter haplotypes associated with protection against the development of reactive arthritis in Finnish patients. Arthritis Rheum 2001 0.80
15 Cytokine gene polymorphisms relevant for the spondyloarthropathies. Curr Opin Rheumatol 2001 0.80
16 Systemic lupus erythematosus. N Engl J Med 1994 0.78
17 Cobalt-specific T lymphocytes in synovial tissue after an allergic reaction to a cobalt alloy joint prosthesis. J Rheumatol 2001 0.77
18 Hepatocellular carcinoma in a patient with hereditary hemochromatosis and noncirrhotic liver. A case report. Pathol Res Pract 1999 0.75
19 Psoriasis: a T-cell-mediated disease? Immunol Today 1996 0.75
20 [ASCO Update 2003 - Highlights of the 39th Meeting of the American Society of Clinical Oncology/ASCO 2003]. Z Gastroenterol 2003 0.75
21 Changes in specific radioactivities of corn-leaf metabolites during photosynthesis in (14)CO 2 and (12)CO 2 at normal and low oxygen. Planta 1974 0.75
22 [ASCO update -- highlights of the 40th Meeting of the American Society of Clinical Oncology/ASCO 2004]. Z Gastroenterol 2004 0.75
23 [On the local efficacy of ciclopiroxolamine in onychomycoses (author's transl)]. Arzneimittelforschung 1981 0.75
24 [The psychosocial status of patients with endogenous eczema. A study using cluster analysis for the correlation of psychological factors with somatic findings]. Hautarzt 1990 0.75
25 [Topical therapy of onychomycoses with 8% ciclopirox laquer. An open, non-comparative study]. Fortschr Med 1993 0.75
26 Early detection of glucocorticoid-specific epidermal alterations using skin surface microscopy. Curr Probl Dermatol 1993 0.75
27 Prednicarbate after different forms of administration. Plasma levels of drug and metabolites and effects on endogenous cortisol levels in humans. Curr Probl Dermatol 1993 0.75
28 Studies on the pharmacokinetics and metabolism of prednicarbate after cutaneous and oral administration. Skin Pharmacol 1993 0.75